Introduction to Ultibro ES ConviCap (Indacaterol + Glycopyrronium)
Ultibro ES ConviCap (Indacaterol + Glycopyrronium) is a prescription medicine used for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD).
Catium ES ConviCap (Indacaterol + Glycopyrronium) is classified under Prescription Medicines, Respiratory Medicines, Dual Bronchodilators, and Long-Acting Inhalation Therapies. It contains Indacaterol (a long-acting beta2-agonist) and Glycopyrronium (a long-acting muscarinic antagonist), which work together to relax airway muscles and improve airflow.
In some markets, Catium ES ConviCap is available as a generic brand containing the same active ingredients, providing similar therapeutic effects under medical supervision.
What Is Ultibro ES ConviCap (Indacaterol + Glycopyrronium)?
Ultibro ES ConviCap (Indacaterol + Glycopyrronium) is the original brand name for the combination of Indacaterol and Glycopyrronium, used for managing COPD in adults.
This combination therapy belongs to a class of medicines called Long-Acting Dual Bronchodilators (LABA + LAMA). These medicines relax airway muscles, open the airways, and improve airflow, reducing COPD symptoms and enhancing exercise capacity.
Generic versions such as Catium ES ConviCap contain the same active compounds and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Indacaterol + Glycopyrronium is classified as a dual long-acting bronchodilator (LABA + LAMA) with complementary actions.
How the Combination Works
It works through several mechanisms:
- Indacaterol stimulates beta2 receptors to relax airway smooth muscles
- Glycopyrronium blocks muscarinic receptors to prevent airway constriction
- Improves airflow and oxygen delivery to the lungs
- Provides long-acting symptom control with once-daily dosing
Through these mechanisms, this combination therapy helps reduce breathlessness, wheezing, and COPD exacerbations.
How Ultibro ES ConviCap (Indacaterol + Glycopyrronium) Works in the Body
COPD causes airway narrowing and breathing difficulty. Ultibro ES ConviCap relaxes airway muscles through two complementary pathways, allowing better airflow and easier breathing.
Key Actions of Indacaterol + Glycopyrronium
- Relaxes bronchial smooth muscles for better airflow
- Reduces shortness of breath, wheezing, and coughing
- Enhances exercise tolerance and daily activity
- Provides 24-hour symptom relief with once-daily dosing
Generic versions such as Catium ES ConviCap deliver the same active compounds, offering similar dual bronchodilator benefits when prescribed appropriately.
Medical Uses of Ultibro ES ConviCap (Indacaterol + Glycopyrronium)
Ultibro ES ConviCap (Indacaterol + Glycopyrronium) is prescribed for adults with COPD to improve lung function and reduce symptoms.
Dual Bronchodilator Therapy for COPD
The combination of Indacaterol and Glycopyrronium provides enhanced airway relaxation compared to single-agent therapy.
Potential Benefits
- Reduces breathlessness and wheezing
- Improves lung function (FEV1) and airflow
- Enhances exercise capacity and daily activity
- Decreases frequency of COPD exacerbations
Generic alternatives like Catium ES ConviCap may also be used under medical supervision.
Who Can Take Catium ES ConviCap?
Because Indacaterol + Glycopyrronium is a prescription medicine, treatment should always be supervised by a healthcare professional.
Eligibility Criteria
Patients may be prescribed Ultibro ES ConviCap (Indacaterol + Glycopyrronium) if they:
- Have a confirmed diagnosis of COPD
- Require dual bronchodilator therapy
- Can tolerate LABA and LAMA therapy
- Are monitored for heart rate, blood pressure, and lung function
Generic options such as Catium ES ConviCap may also be considered depending on availability and physician recommendation.
Who Should Avoid Ultibro ES ConviCap (Indacaterol + Glycopyrronium)
Ultibro ES ConviCap should NOT be used by:
- Patients with hypersensitivity to Indacaterol, Glycopyrronium, or any component of the inhaler
- Individuals with severe cardiovascular conditions (e.g., arrhythmias)
- Patients with severe liver or kidney impairment unless advised by a doctor
- Pregnant or breastfeeding women unless approved by a physician
Ultibro ES ConviCap (Indacaterol + Glycopyrronium) Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Catium ES ConviCap inhalation once daily as directed by the doctor
- Use the ConviCap device correctly to ensure proper drug delivery
- Do not exceed the prescribed dose
- Can be taken with or without food
Dosage Adjustments
Doctors may adjust the dose depending on:
- Severity of COPD symptoms
- Lung function test results
- Tolerance to therapy
- Concomitant medications
Side Effects of
Ultibro ES ConviCap (Indacaterol + Glycopyrronium)
Like all inhaled bronchodilators, Indacaterol + Glycopyrronium may cause side effects.
Common Side Effects
- Cough or throat irritation
- Headache or dizziness
- Nasal congestion or runny nose
- Dry mouth
Serious Side Effects
- Fast or irregular heartbeat (palpitations)
- Severe allergic reactions
- Chest pain or worsening shortness of breath
- Hypokalemia (low potassium levels)
Patients should report any unusual or severe symptoms immediately to their healthcare provider.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the ConviCap device in original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. What is Ultibro ES ConviCap (Indacaterol + Glycopyrronium) used for?
It is used for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve breathing and reduce symptoms.
2. How long does Catium ES ConviCap take to work?
Bronchodilator effects are typically felt within minutes, with full benefits lasting up to 24 hours after inhalation.
3. Can Indacaterol + Glycopyrronium be taken with food?
Yes. Catium ES ConviCap inhalation therapy can be used with or without food.
4. Is Catium ES ConviCap the same as Ultibro ES ConviCap?
Catium ES ConviCap contains Indacaterol + Glycopyrronium, the same active ingredients found in Ultibro ES ConviCap. Generic versions are available. For more info, contact on WhatsApp: https://wa.me/8801742433764
5. Do I need a prescription to buy Catium ES ConviCap (Indacaterol + Glycopyrronium)?
Yes. Catium ES ConviCap is prescription-only and should be used under supervision of a qualified healthcare professional.
Medical Disclaimer
Disclaimer:
The information on this page is for educational purposes only and should not be considered medical advice. Ultibro ES ConviCap (Indacaterol + Glycopyrronium) is a prescription-only medicine and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.
